Levoketoconazole and Ebrotidine: Interaction Details
- Levoketoconazole
- Recorlev
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Levoketoconazole and Ebrotidine interaction:
Levoketoconazole
- Recorlev
Ebrotidine
We don't have a drug information page for Ebrotidine yet. Have a question about Ebrotidine? Ask a pharmacist, free →
What Happens When You Take Levoketoconazole With Ebrotidine
What can happen when they are taken together (rated Major)
Reduced levoketoconazole exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Levoketoconazole should not be taken together with H2 receptor , because these agents may reduce how well levoketoconazole is absorbed.1
The Levoketoconazole and Ebrotidine Interaction, Explained
Ebrotidine may lower how much levoketoconazole your body absorbs. Levoketoconazole (Recorlev) is used to treat high cortisol levels in Cushing's syndrome, and it needs stomach acid to dissolve and be absorbed well. Ebrotidine is an acid-reducing medicine (an H2 blocker). With less stomach acid, you might get less levoketoconazole into your blood, so it may not work as well.
This is a theoretical concern based on how the drugs work, not on proven problems in patients. Please don't stop or change anything on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Reduced levoketoconazole exposure is expected with H2 receptor such as ebrotidine, through impaired .
- Mechanism: levoketoconazole solubility is pH-dependent, so reduced gastric acidity from H2 blockade may lower dissolution and absorption (decreased /). Neither drug's effect here depends on activation.
- Direction: decreased levoketoconazole exposure, with possible loss of cortisol-lowering .
- Evidence: theoretical; onset unspecified; rated major.
- Management: avoid per labeling for H2 receptor antagonists. If acid suppression is needed, review alternatives with the prescriber and monitor clinical response and cortisol control.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Levoketoconazole and Ebrotidine Interact
The likely mechanism
Impaired of levoketoconazole
How to Manage the Levoketoconazole and Ebrotidine Interaction
The documented advice is to avoid using levoketoconazole and H2 blockers like ebrotidine together, because the acid-lowering effect may reduce how well levoketoconazole is absorbed.
- Keep taking your medicines as prescribed until you speak with your care team.
- Tell your pharmacist and prescriber if you take ebrotidine or any other acid reducer, including over-the-counter ones.
- Your care team may look at other ways to handle your stomach symptoms and may monitor you more closely to make sure your treatment is working.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Levoketoconazole or Ebrotidine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Levoketoconazole and Ebrotidine: Common Questions
How serious is the Levoketoconazole and Ebrotidine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Levoketoconazole and Ebrotidine interaction managed?
The documented advice is to avoid using levoketoconazole and H2 blockers like ebrotidine together, because the acid-lowering effect may reduce how well levoketoconazole is absorbed. Keep taking your medicines as prescribed until you speak with your care team. Tell your pharmacist and prescriber if you take ebrotidine or any other acid reducer, including over-the-counter ones. Your care team may lo… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Levoketoconazole and Ebrotidine Interaction
Ask in your own words about taking Levoketoconazole and Ebrotidine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Other Serious Interactions of Levoketoconazole and Ebrotidine
Also serious with Levoketoconazole
- ClindamycinContraindicated
- AmitriptylineContraindicated
- SertralineContraindicated
- BuprenorphineContraindicated
Also serious with Ebrotidine
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.